isibhengezo_sekhasi

umkhiqizo

I-Bosutinib (CAS# 380843-75-4)

Isakhiwo Samakhemikhali:

I-Molecular Formula I-C26H29Cl2N5O3
I-Molar Mass 530.45
Ukuminyana 1.36
I-Melting Point 116-120 ºC
I-Boling Point 649.7±55.0 °C(Kubikezelwe)
I-Flash Point 346.7°C
Ukuncibilika Incibilika ku-DMSO, hhayi emanzini
I-Vapor Presure 0-0Pa ku-20 ℃
Ukubukeka Okuqinile
Umbala okumhlophe ukuya kunsundu ngokukhanyayo
pKa 7.63±0.10(Okubikezelwe)
Isimo Sesitoreji izinga lokushisa legumbi
Ukuzinza Izinzile iminyaka emi-2 kusukela ngosuku lokuthenga njengoba kunikeziwe. Izixazululo ku-DMSO zingagcinwa ku -20°C isikhathi esingafika enyangeni engu-1.
I-Refractive Index 1.651
Isifundo se-in vitro I-Bosutinib inokukhetha okuphezulu kwe-Src kune-non-Src family kinases, ene-IC50 ye-1.2 nM, futhi ivimbela ngempumelelo ukwanda kwamaseli ancike ku-Src, nge-IC50 ye-100 nM. I-Bosutinib ivimbele ngokuphawulekayo ukwanda kwemigqa yeseli leukemia ye-Bcr-Abl-positive KU812, K562, ne-MEG-01 kodwa hhayi i-Molt-4, HL-60, Ramos, kanye nezinye imigqa yeseli ye-leukemia, ne-IC50 ye-5 nM, 20 nM, ngokulandelanayo. , kanye no-20 nM, kusebenza kangcono kune-STI-571. Ngokufanayo ne-STI-571, i-Bosutinib isebenza kumafayibha aguqulayo e-Abl-MLV futhi inomsebenzi okhulayo nge-IC50 ye-90 nM. Ekugxiliseni okungu-50 nM, 10-25 nM, kanye no-200 nM, ngokulandelana, i-Bosutinib ikhiphe i-Bcr-Abl ne-STAT5 kumaseli e-CML kanye ne-v-Abl tyrosine phosphorylation evezwa kumafayibha, lokhu kuphumela ekuvinjweni kwe-phosphorylation ye-Bcr-Abl esiginali yezansi nomfula. /Hk. Nakuba ingakwazi ukuvimbela ukwanda nokusinda kwamangqamuzana omdlavuza webele, inganciphisa kakhulu ukunyakaza nokuhlasela kwamangqamuzana omdlavuza webele, i-IC50 i-250 nM, futhi ithuthukise ukunamathela kwe-intercellular kanye ne-membrane yendawo ye-β-catenin.
Isifundo se-vivo I-Bosutinib yayisebenza kahle kumagundane anqunu aphethe i-Src-transformed fiber xenografts kanye ne-HT29 xenografts ngedosi engu-60 mg/kg ngosuku, ngamavelu e-T/C angu-18% no-30%, ngokulandelana. Ukuphathwa ngomlomo kwe-Bosutinib kumagundane izinsuku ezi-5 kuvimbe kakhulu ukukhula kwamathumba e-K562 ngendlela encike kumthamo. Izimila ezinkulu zaqedwa ngomthamo we-100 mg / kg, ukwelashwa ngesilinganiso se-150 mg / kg kukhishwe izimila ezingenabo ubuthi. Uma kuqhathaniswa nomthelela ku-HT29 isimila esifakwe kabusha, i-Bosutinib ngethamo lika-75 mg/kg, kabili ngosuku, ingavimbela ukukhula kwesimila kumagundane anqunu athwele isimila esifakwe i-Colo205, awubanga khona umphumela ophakeme ngemva kokwenyusa umthamo, kodwa i-50 mg/ kg umthamo awubanga namphumela.

Imininingwane Yomkhiqizo

Omaka bomkhiqizo

Izimpawu Eziyingozi Xi - Irritant
Amakhodi Engozi 36 - Ukucasula emehlweni
Incazelo Yokuphepha 26 - Uma uthintana namehlo, geza ngokushesha ngamanzi amaningi futhi ufune iseluleko sezokwelapha.
I-WGK Germany 3
Ikhodi ye-HS 29335990

 

Isingeniso

I-Bosutinib iyi-double inhibitor ye-Src/Abl ene-IC50 ye-1.2 nM kanye ne-1 nM, ngokulandelanayo.


  • Okwedlule:
  • Olandelayo:

  • Bhala umyalezo wakho lapha futhi usithumelele wona